Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Balding men have higher heart disease risk.

Hibiscus petals improved blood sugar and stress responses in diabetic rats.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Bariatric surgery improves skin conditions and metabolism but may cause nutritional deficiencies and hair loss.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Patients with chronic kidney disease on hemodialysis often have skin problems.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

SLE and DM can coexist but are rare and need careful evaluation.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Early hair loss may indicate prostate issues.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.